DexCom, Inc.

DXCM Healthcare Medical Devices

DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024.

Revenue
+11.2%
EPS
0.00%
Free cash flow
−52.9%
Total debt
+0.31%

Quarter to September 2026, against a year earlier

79.91 4.55 −5.39%
Market cap
$31.5B
P/E
32.6×
Fwd P/E
31.8×
Dividend yield
—
F-score
8/9
Altman Z
6.43
Beneish M
−2.70
Dividend safety
n/a

DexCom, Inc. (DXCM) Operating margin

Alert me on Operating margin

DexCom, Inc.'s operating margin over the twelve months to 30 September 2026 was 24.0%, up 4.4 percentage points from fiscal 2025 (19.6%). Over the past ten years it has ranged from −18.1% (fiscal 2018) to 19.6% (fiscal 2025) — the current reading is the highest in ten years. That is above the Medical Devices industry median of −15.1% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2025 19.6% 4.68
FY2024 14.9% (1.62)
FY2023 16.5% 3.06
FY2022 13.4% 2.58
FY2021 10.9% (4.68)
FY2020 15.5% 5.90
FY2019 9.64% 27.70
FY2018 −18.1% (12.14)
FY2017 −5.92% 5.23
FY2016 −11.2% 3.05

Quarterly newest first

Period Operating margin Change (points)
Sep 2026 24.3% 0.01
Jun 2026 24.3% 2.91
Mar 2026 21.4% (4.22)
Dec 2025 25.6% 5.59
43 more quarters

Against its own ten years

Low −18.1% High 19.6%
Ten-year median 10.9%
Current reading's percentile 100

Operating margin against peers

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on DXCM